In an investigation of PC health disparities, gene set enrichment analysis showed oncogenic gene signatures, including KRAS and ERBB2, were enriched in patients expressing high KRT15 and KRT19 associated with poor androgen deprivation therapy (ADT) response after radical prostatectomy. Here, ERBB2 is linked to pachyonychia congenita.